Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 97,834 | 54,043 | 13,661 | 0 | 0 |
| Operating Income | -97,834 | -54,043 | -13,661 | N/A | N/A |
| Other Income | -10,548 | 1,864 | -272 | 0 | 0 |
| Pre-tax Income | -108,382 | -52,179 | -13,933 | 0 | 0 |
| Income Tax | 161 | 85 | N/A | N/A | N/A |
| Net Income Continuous | -108,543 | -52,264 | -13,933 | N/A | N/A |
| Net Income | $-108,543 | $-52,264 | $-13,933 | $N/A | $N/A |
| EPS Basic Total Ops | -271.75 | -651.00 | -292.25 | N/A | N/A |
| EPS Basic Continuous Ops | -271.68 | -651.02 | -292.22 | N/A | N/A |
| EPS Diluted Total Ops | -271.75 | -651.00 | -292.25 | N/A | N/A |
| EPS Diluted Continuous Ops | -271.68 | -651.02 | -292.22 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -271.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-94,275 | $-52,621 | $-11,921 | $N/A | $N/A |